Industry News
Feature: Proteomics’ open book
In the beginning, there was the Human Genome Project. For all its epochal significance, it was little more than that: a beginning. It delivered the first 3.5 billion base-pair DNA sequence of a human being, along with a near-complete catalogue of 20,000-odd genes, and a map showing where each gene located on our 22 pairs of autosomes and pigeon-paired sex chromosomes. [ + ]
Patrys closes $2.85m capital raising
Patrys (ASX:PAB) has completed the share purchase plan component of a capital raising worth $2.85 million. The clinical stage biopharmaceutical company fell just shy of hitting the maximum target for the capital raising of $2.9 million. [ + ]
Winning research-based ideas blaze a bright trail for the future
New approaches to cancer treatment and improved nickel mining output were the winning ideas from the Grand Final of UniQuest’s annual Trailblazer innovative ideas competition, held at The University of Queensland (UQ) on 4 September 2012. [ + ]
CBio now Invion after completing merger
Australian drug developer CBio has completed its merger with US-based Inverseon and formally changed its name to Invion (ASX:IVX). [ + ]
AstraZeneca evaluating Starpharma cancer drugs
Starpharma's (ASX:SPL) cancer drug development platform has attracted the attention of UK pharmaceutical giant AstraZeneca. [ + ]
FDA decision on MoxDuo expected mid-2013
After being cleared to submit existing trial data to back up its IND application for pain formulation MoxDuo IR, QRxPharma (ASX:QRX) now expects the US FDA to make its decision in mid-2013. [ + ]
Iluvien may get UK NHS listing
pSivida (ASX:PVA) licensee Alimera has scored a win in efforts to gain UK acceptance for the Iluvien micro-insert as a treatment for chronic diabetic macular edema (DME). [ + ]
AusBiotech announces 2012 AGM and Board elections
AusBiotech has announced it will hold its annual general meeting at the AusBiotech 2012 national conference in Melbourne on Thursday 1 November 2012 at 1:00pm, where business will include the outcome of the election for two directors to join the AusBiotech Board. [ + ]
ENCODE yields insights into the deeper genome
It has taken nearly a decade of hard work, but the first pages of an ‘Encyclopaedia Genomica’ have been published by an international consortium of researchers, revealing some surprising insights about the human genome. [ + ]
NSW kicks off medical devices fund
The NSW government has launched a seven-figure fund to encourage the development and commercialisation of innovative medical devices in the state. [ + ]
Avita launches capital raising for spray-on skin
Avita Medical (ASX:AVH) will raise up to $10m through a placement and SPP to support marketing and US commercialisation efforts for its ReCell Spray-On Skin technology. [ + ]
Young Australian scientists to meet Nobel Laureates
The best young Australian scientists will have the chance to be mentored by Nobel Prize winners, thanks to a new collaboration between the Australian Academy of Science and the Science and Industry Endowment Fund. [ + ]
AusBiotech 2012: Program now available for industry event of the year
The event, to be held in Melbourne – 30 October - 2 November 2012 – will feature expert speakers from overseas and Australia, who will speak on investment, public policy, industry experiences and business development. [ + ]
Innate Immunotherapeutics to raise US$10m for Australian MS trial
New Zealand's Innate Immunotherapeutics has launched a US$10 million ($9.75 million) capital raising to help fund an Australian trial of a prospective treatment for progressed multiple sclerosis. [ + ]
Azure Healthcare swings to profit for FY12
Azure Healthcare (ASX:AZV), shed of its unprofitable audio visual business, swung to a $744,000 net profit for FY12. [ + ]